All In Biotech

Drug Trial Radar · NCT00895011

Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study of the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy

Last checked: Nov 20, 2026Latest source record: Oct 1, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 298 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

298

Actual

Start

Apr 2009

Primary completion

Apr 2011

Study completion Apr 2011

Sponsor

Lead sponsor
VIVUS LLCIndustry
Sponsor type
Industry
First posted
May 7, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
Male only, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objectives of this study are to evaluate the safety and efficacy of two doses of avanafil in the treatment of adult males for erectile dysfunction following bilateral nerve-sparing radical prostatectomy.

Conditions

  • Erectile Dysfunction

Interventions

  • PlaceboDrug

    One dose 30 minutes prior to initiation of sexual activity

  • AvanafilDrug

    One dose 30 minutes prior to initiation of sexual activity

  • AvanafilDrug

    One dose 30 minutes prior to initiation of sexual activity

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Percentage of Sexual Attempts in Which Subjects Are Able to Maintain an Erection of Sufficient Duration to Have Successful IntercourseTime frame: Baseline, Week 12
  2. The Change in Percentage of Sexual Attempts in Which Subjects Are Able to Insert the Penis Into the Partner's VaginaTime frame: Baseline, Week 12
  3. Change in International Index of Erectile Function - Erectile Function Domain (IIEF-EF) ScoreTime frame: Baseline, End of Treatment (up to 12 weeks)

Locations

51 sites in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Phoenix, Arizona

  • Research Site

    Laguna Hills, California

  • Research Site

    Los Angeles, California

  • Research Site

    Los Angeles, California

  • Research Site

    Sacramento, California

  • Research Site

    Aurora, Colorado

  • Research Site

    Englewood, Colorado

  • Research Site

    Parker, Colorado

  • Research Site

    Washington D.C., District of Columbia

  • Research Site

    Jacksonville, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Trinity, Florida

  • Research Site

    Chicago, Illinois

  • Research Site

    Chicago, Illinois

  • Research Site

    Springfield, Illinois

  • Research Site

    Indianapolis, Indiana

  • Research Site

    New Orleans, Louisiana

  • Research Site

    Shreveport, Louisiana

  • Research Site

    Baltimore, Maryland

  • Research Site

    Towson, Maryland

  • Research Site

    Brighton, Massachusetts

  • Research Site

    Burlington, Massachusetts

  • Research Site

    Jamaica Plain, Massachusetts

  • Research Site

    Ann Arbor, Michigan

  • Research Site

    Hackensack, New Jersey

  • Research Site

    Lawrenceville, New Jersey

  • Research Site

    Brooklyn, New York

  • Research Site

    Brooklyn, New York

  • Research Site

    Garden City, New York

  • Research Site

    Great Neck, New York

  • Research Site

    New York, New York

  • Research Site

    New York, New York

  • Research Site

    New York, New York

  • Research Site

    Poughkeepsie, New York

  • Research Site

    Durham, North Carolina

  • Research Site

    Greensboro, North Carolina

  • Research Site

    Cincinnati, Ohio

  • Research Site

    Cleveland, Ohio

  • Research Site

    Bala-Cynwyd, Pennsylvania

  • Research Site

    Philadelphia, Pennsylvania

Showing 40 of 51 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.